As of 2025-07-04, the EV/EBITDA ratio of Immunome Inc (IMNM) is -2.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMNM's latest enterprise value is 511.56 mil USD. IMNM's TTM EBITDA according to its financial statements is -175.73 mil USD. Dividing these 2 quantities gives us the above IMNM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.1x | 12.8x |
| Forward P/E multiples | 17.1x - 32.0x | 20.6x |
| Fair Price | (31.61) - (23.54) | (30.77) |
| Upside | -457.6% - -366.3% | -448.0% |
| Date | EV/EBITDA |
| 2025-06-13 | -3.09 |
| 2025-06-12 | -3.38 |
| 2025-06-11 | -3.23 |
| 2025-06-10 | -3.27 |
| 2025-06-09 | -3.12 |
| 2025-06-06 | -3.05 |
| 2025-06-05 | -3.05 |
| 2025-06-04 | -3.00 |
| 2025-06-03 | -3.12 |
| 2025-06-02 | -3.02 |
| 2025-05-30 | -2.87 |
| 2025-05-29 | -2.97 |
| 2025-05-28 | -2.81 |
| 2025-05-27 | -2.79 |
| 2025-05-23 | -2.74 |
| 2025-05-22 | -2.72 |
| 2025-05-21 | -2.46 |
| 2025-05-20 | -2.77 |
| 2025-05-19 | -2.50 |
| 2025-05-16 | -2.52 |
| 2025-05-15 | -2.50 |
| 2025-05-14 | -2.48 |
| 2025-05-13 | -2.45 |
| 2025-05-12 | -2.47 |
| 2025-05-09 | -2.23 |
| 2025-05-08 | -2.35 |
| 2025-05-07 | -2.21 |
| 2025-05-06 | -2.31 |
| 2025-05-05 | -2.74 |
| 2025-05-02 | -2.92 |
| 2025-05-01 | -2.92 |
| 2025-04-30 | -2.89 |
| 2025-04-29 | -2.76 |
| 2025-04-28 | -2.78 |
| 2025-04-25 | -2.69 |
| 2025-04-24 | -2.75 |
| 2025-04-23 | -2.74 |
| 2025-04-22 | -2.59 |
| 2025-04-21 | -2.50 |
| 2025-04-17 | -2.45 |
| 2025-04-16 | -2.08 |
| 2025-04-15 | -2.20 |
| 2025-04-14 | -2.17 |
| 2025-04-11 | -2.05 |
| 2025-04-10 | -1.60 |
| 2025-04-09 | -1.61 |
| 2025-04-08 | -1.29 |
| 2025-04-07 | -1.45 |
| 2025-04-04 | -1.47 |
| 2025-04-03 | -1.62 |